Placeholder Banner

BIO Response to Biotech RFI

February 5, 2023

BIO has submitted comments to the Office of Science & Technology Policy on how regulations underpinning the Coordinated Framework for the Regulation of Biotechnology can better facilitate the use of biotechnology to stimulate the economy and to enable products that further societal goals related to health, climate change and energy, food and agricultural innovation, resilient supply chains, and innovative scientific advances.

Download Full Comments Below
BIO Response to Biotech RFI
Discover More
BIO and BIO members are urging lawmakers to enact a short-term extension of the MCM-PRV program while Congress is waiting to address a full reauthorization with PAHPA.
BIO response to Federal Trade Commission request for comment on the agency's Guides for the Use of Environmental Marketing Claims (Green Guides)
The Council of State Bioscience Associations (CSBA) is an alliance of independent, state and territory based, non-profit trade associations, each of which advocates for public policies that support responsible development and delivery of innovative…